Hospital Infection Control & Prevention – January 1, 2019
January 1, 2019
View Issues
-
Candida auris Hides in Reservoir Sites, Moves Across Healthcare Continuum
Multidrug-resistant Candida auris continues to threaten national emergence from endemic areas, finding safe harbor in step-down facilities and moving across the continuum to infect other patients.
-
Candida auris Reportable Nationally in 2019
Candida auris is reportable nationwide this year, a move that should boost surveillance of an emerging pathogen that has been primarily confined in three states: New York, New Jersey, and Illinois.
-
Internet Trolls Fuel Vaccine Misinformation
In the wake of preventable infectious disease outbreaks and the ensuing controversy about vaccination, social media has become a battlefield of divisive rhetoric, some of it posted just to create the illusion of a “debate” and keep people divided.
-
CDC Debunks Flu Shot/Pregnancy Misinformation
Fighting off another flu vaccine falsehood, the Centers for Disease Control and Prevention says it is not recommending that pregnant women get their doctors’ approval before they “get vaccinated at a worksite clinic, pharmacy, or other location outside of their physician’s office.”
-
Will Paralytic Syndrome Fade With Fall?
As the fall 2018 viral season ended, there was hope that the national outbreak of acute flaccid myelitis (AFM) in children would follow historic patterns and fade out as well. -
APIC, CDC Develop Infection Cards
The Association for Professionals in Infection Control and Epidemiology has teamed up with the CDC to create “quick assessment” cards with infection prevention tips on various patient populations or care environments.
-
Devil in the Details in CDC Infection Control Draft
The CDC has issued draft guidelines for preventing infections in healthcare workers, urging collaboration between infection preventionists and employee health professionals. -
New Drugs Needed for Bad Bugs
To stem the tide of antibiotic-resistant pathogens, the FDA will provide more incentives and market opportunities in 2019 as part of a five-year plan to get the pharmaceutical industry involved in restoring the dwindling drug pipeline.